e-Drug3D

1567

M QUETIAPINE


INN
QUETIAPINE

(is an active metabolite)

cas 5747-48-8
CLASS

NERVOUS SYSTEM
ANTIPSYCHOTIC
SCHIZOPHRENIA
DIBENZOTHIAZEPINE FAMILY
DOPAMINE D2 RECEPTOR ANTAGONIST (IC50=329 NANOMOLAR)
SEROTONIN (5HT2) ANTAGONIST (IC50=148 NANOMOLAR)
SEROTONIN 5HT1A ANTAGONIST (IC50=717 NANOMOLAR)
DOPAMINE D1 ANTAGONIST (IC50=1268 NANOMOLAR)
HISTAMINE H1 ANTAGONIST (IC50=30 NANOMOLAR)
ADRENERGIC ALPHA 1 RECEPTOR ANTAGONIST (IC50= 94 NANOMOLAR)
ADRENARGIC ALPHA 2 RECEPTOR ANTAGONIST (IC50=271 NANOMOLAR)
NO APPRECIABLE AFFINITY AT CHOLINERGIC MUSCARINIC AND BENZODIAZEPINE RECEPTORS (IC50 SUPERIOR TO 5000 NANOMOLAR)

ROUTE (list)

-

ATC code

N05AH04

PK parameters

Target

TARGET 5-HYDROXYTRYPTAMINE 2 RECEPTOR
D2 DOPAMINE RECEPTOR

DrugCentral

D(2) dopamine receptor UNIPROT P14416 DRD2

5-hydroxytryptamine receptor 2A UNIPROT P28223 HTR2A

Download SDF file Dibenzo[b,f][1,4]thiazepine, 11-(1-piperazinyl)-

Formula:
C17H17N3S

Calculated chemical properties:

MW 295.41
NB_atoms 21
XLogP 3.13
PSA 25.567
NB_HD 1
NB_HA 3
fsp3 0.24
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL